Home/Filings/4/0001209191-20-004742
4//SEC Filing

Horn Patrick Taylor 4

Accession 0001209191-20-004742

CIK 0001322505other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 7:28 PM ET

Size

7.7 KB

Accession

0001209191-20-004742

Insider Transaction Report

Form 4
Period: 2020-01-21
Horn Patrick Taylor
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2020-01-22$24.29/sh443$10,7604,557 total
  • Award

    Stock Option (right to buy)

    2020-01-21+31,50031,500 total
    Exercise: $24.67Exp: 2030-01-20Common Stock (31,500 underlying)
Footnotes (3)
  • [F1]Shares sold pursuant to a Rule 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F2]Represents 807 shares of common stock and 3,750 restricted stock units.
  • [F3]This option vests as to 25% of the shares on January 21, 2021, with the remainder vesting in equal installments every three months thereafter beginning on April 21, 2021 and ending on January 21, 2024, provided that the vesting of the option may be accelerated, in whole or in part, based on the achievement of certain pre-established company performance criteria, but in no event prior to January 21, 2021.

Issuer

ALBIREO PHARMA, INC.

CIK 0001322505

Entity typeother

Related Parties

1
  • filerCIK 0001572002

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 7:28 PM ET
Size
7.7 KB